New Evidence Available

Updated Recommendation

A new evidence synthesis was published:2025, Medical eligibility criteria for contraceptive use, 6th ed.

View latest version (2025)

Bibliographic information

GuidelineMedical eligibility criteria for contraceptive use
Year of Publication2015
Issuing InstitutionWorld Health Organization

Recommendation

Retired

Medical eligibility criteria for contraceptive use. Women living with HIV using antiretroviral therapy (ART). Women taking any Protease inhibitor (PI) can generally use the levonorgestrel-releasing intrauterine device(LNG-IUD), provided that their HIV clinical disease is asymptomatic or mild (WHO Stage 1 or 2).